Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of this study is to evaluate the effects and safety of pioglitazone and berberine on the basis of lifestyle intervention to non-alcoholic fatty liver disease patients with impaired glucose regulation or type 2 diabetes mellitus.
Epistemonikos ID: 337d9993f7500b3f34dc9c7e5cb666541732e75f
First added on: Mar 26, 2024